YouthBio CEO: The time is right to develop epigenetic reprogramming therapies
|
|
0
|
374
|
May 18, 2022
|
CRISPR technologies for precise epigenome editing
|
|
2
|
467
|
May 18, 2022
|
Vascular, Neurologic and Hormonal Abnormalities in Men with Persistent Sexual Dysfunction After Discontinuation of Finasteride: Carlisle et al., 2022
|
|
17
|
1435
|
May 13, 2022
|
Researchers Use CRISPR to Reset Anxiety, Alcohol Use Disorder
|
|
0
|
424
|
May 8, 2022
|
Gene Discovery Allows the Production of Inner or Outer Ear Hair Cells (Northwestern University)
|
|
0
|
309
|
May 8, 2022
|
Team uses MRI to image epigenetics in brain
|
|
4
|
755
|
May 4, 2022
|
AI-designed protein can awaken silenced genes one-by-one
|
|
1
|
496
|
May 3, 2022
|
Rare genetic disease ADNP Syndrome to be cured within 3 years
|
|
0
|
443
|
May 3, 2022
|
Scientists Discover Genetic Cause of Lupus
|
|
0
|
331
|
May 2, 2022
|
MIT Scientists Develop New Regenerative Drug That Reverses Hearing Loss
|
|
4
|
550
|
April 30, 2022
|
Recovery of penile fibrosis, is it possible?
|
|
10
|
2060
|
April 28, 2022
|
Hypermethylation of ERα & Smooth Muscle Cells
|
|
1
|
541
|
April 11, 2022
|
Link identified between inflammation and brain fog
|
|
15
|
1570
|
February 28, 2022
|
Non-cell autonomous disruption of nuclear architecture as a potential cause of COVID-19 induced anosmia
|
|
0
|
335
|
February 7, 2022
|
Androgen Receptor upregulation for receptor resensitization
|
|
6
|
1261
|
February 1, 2022
|
Up to 15% finasteride side effects and not 2% and 0,3% to 2,1% permanent side effects
|
|
1
|
595
|
January 31, 2022
|
CIALIS increases or decreases the androgen receptor?
|
|
5
|
1081
|
January 31, 2022
|
An article about brain fog and "chemo brain"
|
|
0
|
405
|
January 28, 2022
|
Interesting use of mRNA technology
|
|
1
|
456
|
January 11, 2022
|
Found out I have above range 5ar activity
|
|
6
|
1040
|
January 9, 2022
|
Scientists discover brain region that responds to clitoris
|
|
0
|
422
|
December 22, 2021
|
Accutane : Comparative analysis between Tretinoin (anti-cancer) and Isotretinoin (anti-acne)
|
|
3
|
650
|
November 27, 2021
|
Finasteride and dry eye
|
|
6
|
1162
|
November 12, 2021
|
Dr. Michael S. Irwig - Late 2021 Medical Journal Publication
|
|
16
|
1504
|
November 11, 2021
|
How routine pharmacovigilance failed to identify finasteride's persistent sexual side effects
|
|
7
|
871
|
November 9, 2021
|
On the way to ICD 10 for PFS, PSSD and PAS? - Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
|
|
5
|
726
|
November 8, 2021
|
CiteDiagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin
|
|
2
|
420
|
October 29, 2021
|
Retinoic Acid and Depressive Disorders Evidence and Possible Neurobiological Mechanisms
|
|
2
|
402
|
October 28, 2021
|
"The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression"
|
|
3
|
734
|
October 26, 2021
|
Is finasteride intake associated with penile curvature/peyronie’s disease? Assessment of both the food and drug administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
|
|
3
|
425
|
October 26, 2021
|